Table 1.
Underlying characteristics between two groups with and without ABPA.
| Characteristics | Group with ABPA | Group without ABPA | P value |
|---|---|---|---|
| IgE >500 IU/mL | |||
| Male gender | 11 (61.1) | 24 (42.9) | 0.177 |
| Mean age, year | 10.94 ± 3.64 | 6.61 ± 4.47 | <0.001 |
| Mean serum IgE level | 919.32 ± 323.94 | 124.67 ± 133.09 | <0.001 |
| Mean FEV1 | 54.32 ± 20.86 | 62.15 ± 24.55 | 0.367 |
| Mean FEV1/FVC | 76.88 ± 14.71 | 88.76 ± 22.96 | 0.076 |
| Prevalence of bronchocele | 17 (94.4) | 33 (58.9) | <0.001 |
| Mean bronchocele attenuation | 54.23 ± 34.20 | 34.57 ± 13.09 | 0.005 |
| IgE >1000 IU/mL | |||
| Male gender | 5 (62.5) | 30 (45.5) | 0.464 |
| Mean age, year | 11.62 ± 3.73 | 7.18 ± 4.54 | 0.010 |
| Mean serum IgE level | 1224.62 ± 71.77 | 208.60 ± 246.52 | 0.001 |
| Mean FEV1 | 65.80 ± 25.02 | 59.12 ± 23.63 | 0.644 |
| Mean FEV1/FVC | 85.96 ± 11.61 | 84.94 ± 22.05 | 0.937 |
| Mean bronchocele attenuation | 69.21 ± 47.98 | 36.71 ± 14.10 | 0.001 |